- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3276EUR$3,600USD£2,809GBP
- Report
- July 2022
- 255 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- May 2023
- 160 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- October 2022
- 177 Pages
From €3140EUR$3,450USD£2,692GBP
- Report
- October 2022
- 174 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- October 2022
- 181 Pages
Africa, Middle East
From €3140EUR$3,450USD£2,692GBP
- Report
- October 2022
- 202 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2024
- 106 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 181 Pages
Europe
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 150 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2024
- 85 Pages
Spain
From €3185EUR$3,500USD£2,731GBP
- Report
- September 2024
- 80 Pages
France
From €3185EUR$3,500USD£2,731GBP
- Report
- January 2021
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 143 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 85 Pages
North America
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4323EUR$4,750USD£3,706GBP

Humulin is a brand of insulin used to treat endocrine and metabolic disorders. It is a recombinant human insulin, produced by genetically engineered bacteria, and is used to treat diabetes mellitus. It is available in several forms, including short-acting, intermediate-acting, and long-acting. Humulin is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is also used to treat other endocrine and metabolic disorders, such as hyperglycemia, hypoglycemia, and polycystic ovary syndrome.
Humulin is a widely used insulin, and is available in many countries around the world. It is available in both generic and branded forms, and is available in both injectable and oral forms. It is also available in combination with other medications, such as metformin and glipizide.
The Humulin market is highly competitive, with many companies offering their own versions of the drug. Some of the major companies in the market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more